Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Biocryst Pharma Inc (BCRX)
Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Shares of BioCryst Pharmaceuticals Jumped Today

A day after the stock plummeted, it bounced back.

BCRX : 8.50 (+4.68%)
Why BioCryst Pharmaceuticals Stock Is Sinking Today

Investors didn't like the drugmaker's Q4 update.

BCRX : 8.50 (+4.68%)
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript

BCRX earnings call for the period ending December 31, 2022.

BCRX : 8.50 (+4.68%)
BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Tops Revenue Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of -100% and 6.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

BCRX : 8.50 (+4.68%)
ACRS : 8.01 (-1.72%)
BioCryst: Q4 Earnings Snapshot

BioCryst: Q4 Earnings Snapshot

BCRX : 8.50 (+4.68%)
Why Earnings Season Could Be Great for BioCryst (BCRX)

BioCryst (BCRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BCRX : 8.50 (+4.68%)
Earnings Preview: Ionis Pharmaceuticals (IONS) Q4 Earnings Expected to Decline

Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IONS : 33.95 (+0.98%)
BCRX : 8.50 (+4.68%)
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BCRX : 8.50 (+4.68%)
IRWD : 10.69 (+1.71%)
Neurocrine Biosciences (NBIX) Lags Q4 Earnings Estimates

Neurocrine (NBIX) delivered earnings and revenue surprises of -23.48% and 0.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

NBIX : 97.05 (+1.42%)
BCRX : 8.50 (+4.68%)
Wall Street Analysts Predict a 48% Upside in BioCryst (BCRX): Here's What You Should Know

The mean of analysts' price targets for BioCryst (BCRX) points to a 47.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

BCRX : 8.50 (+4.68%)

Barchart Exclusives

2 Stocks to Buy With Unusual Options Activity Other Than Tesla
Six out of Thursday’s top 10 options based on volume exhibiting unusual options activity were Tesla. That’s not surprising. What was is that TSLA had zero in the top 25 when it comes to the Vol/OI ratio. These two stocks did. They’re potential long-term buys.   Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar